Hamlet BioPharma Enters Commercial Collaborations with Top International Advisory Firms to Enhance Partnering and Strategic Alliances
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce that it has entered into commercial collaborations with two premier international advisory firms. Under the new collaborations, the advisory firms will offer expert support to Hamlet BioPharma, leveraging their global networks and deep industry knowledge to identify and negotiate potential partnerships for commercial opportunities and strategic alliances. “The collaborations are expected to accelerate Hamlet BioPharma’s strategic partnering initiatives